Physician profile
Laura Starkey
NPI 1336655984
$1,117.08
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.73 · 2022: $50.00 · 2023: $23.05 · 2024: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.12 | 2024 | |
| Inspire Medical Systems, INC. | $243.76 | 2024 | Inspire |
| Alexion Pharmaceuticals, INC. | $124.99 | 2024 | |
| Neurelis, INC. | $113.47 | 2024 | Valtoco |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.77 | 2024 | Xifaxan |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $96.97 | 2024 | |
| Sanofi-Aventis U.S. LLC | $90.22 | 2024 | |
| Novo Nordisk INC | $50.00 | 2022 | |
| Indivior INC. | $23.05 | 2023 | Perseris |
| Abbott Laboratories | $18.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Starkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.